PD-1 checkpoint blockade in advanced melanoma patients: NK cells, monocytic subsets and host PD-L1 expression as predictive biomarker candidates

Blockade of the PD-1 receptor has revolutionized the treatment of metastatic melanoma, with significant increases in overall survival (OS) and a dramatic improvement in patient quality of life. Despite the success of this approach, the number of benefitting patients is limited and there is a need fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Pico de Coaña, Yago, Wolodarski, Maria, van der Haar Àvila, Irene, Nakajima, Takahiro, Rentouli, Stamatina, Lundqvist, Andreas, Masucci, Giuseppe, Hansson, Johan, Kiessling, Rolf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470181/
https://www.ncbi.nlm.nih.gov/pubmed/32939320
http://dx.doi.org/10.1080/2162402X.2020.1786888

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470181/
https://www.ncbi.nlm.nih.gov/pubmed/32939320
http://dx.doi.org/10.1080/2162402X.2020.1786888

Ejemplares similares